This Is No Time for ‘America First.’ China’s Coronavirus Tests Are Good Enough for the U.S.

“The Chinese biotechnology sector has outpaced companies in the United States to develop effective tests for COVID-19. Regulators in Europe have moved quickly to approve and import clinical tests from China. It is time for the Trump administration to follow suit.”

Contributing on, Eben Kirksey, Friends of the Institute for Advanced Study Member in the School of Social Science, calls for viable coronavirus tests in the international marketplace to be made accessible in the U.S., arguing that “Rather than waiting to see which products emerge from the market, administration officials need to urgently provide more leadership. Government scientists could be identifying COVID-19 tests that have already proved to be effective in other parts of the world and targeting these tests for expedited approval.”